Cuffless portfolio enhances tracheostomy care and safety for young
BOULDER, Colo.--(BUSINESS WIRE)--Apr. 15, 2013--
(NYSE: COV), a leading global provider of healthcare products and
recognized innovator in patient monitoring and respiratory care devices,
today added a new product to its family of ShileyTM neonatal
and pediatric tracheostomy tubes. The new cuffless product will help
enhance patient care and safety within the hospital and home care
“This new product portfolio represents an important step forward in the
care of young patients dependent on tracheostomy tubes,” said Robert J.
White, President, Respiratory and Monitoring Solutions, Covidien. “For
more than 40 years, clinicians and patients have trusted the Shiley
brand for their tracheostomy needs. We are pleased to offer an expanded
range of industry-leading solutions for meeting their needs across
hospital and home care environments.”
Shiley portfolio innovations for the cuffless design include:
An expanded range of tube sizes down to a 2.5mm inner diameter to
accommodate the smallest patients – an option that hasn’t previously
existed in the Shiley portfolio.
A soft, clear flange that facilitates easier examination of the
underlying skin for infection and eases trach-tube holder insertion.
Tubes manufactured with a medical grade PVC, with a citric-based,
non-phthalate plasticizer and meet the latest patient safety standards.
The Shiley neonatal and pediatric tracheostomy tubes were recently
approved for sale in the United States, Canada and Europe. More
information on the product portfolio is available by visiting Covidien.com/RMS.
Covidien also offers tracheostomy support resources for patients and
physicians through its recently enhanced website LivingwithaVent.com.
Covidien is a leading global healthcare products company that creates
innovative medical solutions for better patient outcomes and delivers
value through clinical leadership and excellence. Covidien manufactures,
distributes and services a diverse range of industry-leading product
lines in three segments: Medical Devices, Pharmaceuticals and Medical
Supplies. With 2012 revenue of $11.9 billion, Covidien has 43,000
employees worldwide in 70 countries, and its products are sold in over
Please visit Covidien.com
to learn more about our business.
Rhonda Luniak, 303-305-2263
Lannum, CFA, 508-452-4343